Is Beam Therapeutics Inc. overvalued?

Beam Therapeutics Inc. (BEAM) — key valuation metrics and fundamentals.

No verdict

Price

$26.41

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$2.72B

Dividend yield

3.4%

Return on equity

-7.7%

Sector

Healthcare

Fair value compares BEAM's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks